相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
该BioSIM 抗人 LIGHT 抗体 (奎索利单抗),生物类似药,科研用途 [ CAS: 2427667-03-4]的免疫原请参考该产品的说明书
- 保存条件:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 克隆性:
单克隆
- 适应物种:
Human
- 保质期:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 级别:
科研级别
- 库存:
999
- 供应商:
亚科因(Abbkine)
- 宿主:
Human
- 应用范围:
ELISA, FACS, Functional assay, Research in vivo
- 抗体英文名:
LIGHT
- 抗体名:
LIGHT
- 规格:
1mg
BioSIM 抗人 LIGHT 抗体 (奎索利单抗),生物类似药
产品概述
BioSIM anti-Human LIGHT Antibody (Quisovalimab Biosimilar) 是一种高质量的科研级二抗,专为研究LIGHT (TNFSF14) 信号通路相关疾病而设计。该抗体作为奎索利单抗的生物类似药,在无动物成分的设施中生产,采用无蛋白细胞培养技术,确保产品的纯净度和一致性。
产品信息
- 英文名称:BioSIM anti-Human LIGHT Antibody (Quisovalimab Biosimilar), Research Grade
- 中文名称:BioSIM 抗人 LIGHT 抗体 (奎索利单抗),生物类似药,科研用途
- CAS号:2427667-03-4
- 产品类型:二抗
- 供应商:InvivoCrown
- 产品货号:SIM0478-1mg
- 产品规格:1mg
- 来源宿主:Human
- 反应性:Human
生产与纯化工艺
该重组生物类似抗体采用先进的生产工艺,在无动物成分的设施中生产,仅使用体外的无蛋白细胞培养技术。产品经过多步骤的纯化过程,其中包括采用Protein A或G的色谱工艺,确保高纯度和低内毒素水平,适合各种严谨的科研应用。
研究领域与应用
主要研究领域:
- 哮喘病理机制研究
- 成人呼吸窘迫综合征(ARDS)探索
- 急性肺损伤(ALI)相关研究
应用类型:
- ELISA:适用于LIGHT蛋白的定量检测
- FACS:可用于细胞表面LIGHT表达的流式细胞术分析
- Functional assay:LIGHT信号通路功能性研究
- Research in vivo:体内疾病模型研究
技术参数
- 免疫原性:详细信息请参考产品说明书
- 交叉反应性:与人LIGHT蛋白特异性结合
- 保存条件:
- 短期保存(1-2周):4°C
- 中期保存:-20°C,最长12个月
- 长期保存:-80°C
- 注意事项:避免反复冻融,以确保抗体活性
订购信息
产品货号:SIM0478-1mg
规格:1mg
供应商:InvivoCrown
注:本产品仅限科研用途,不用于诊断或治疗目的。详细技术信息请参阅产品说明书或联系我们的技术支持团队。
注意:以上信息可能随着产品优化升级等因素产生变动,具体信息请咨询亚科因公司。

BioSIM anti-Human LIGHT Antibody (Quisovalimab Biosimilar)
Product Overview
BioSIM anti-Human LIGHT Antibody (Quisovalimab Biosimilar) is a high-quality research-grade secondary antibody designed for studying diseases related to the LIGHT (TNFSF14) signaling pathway. As a biosimilar of Quisovalimab, this antibody is produced in animal component-free facilities using protein-free cell culture technology to ensure product purity and consistency.
Product Information
- English Name: BioSIM anti-Human LIGHT Antibody (Quisovalimab Biosimilar), Research Grade
- Chinese Name: BioSIM anti-Human LIGHT Antibody (Quisovalimab Biosimilar), for Research Use
- CAS Number: 2427667-03-4
- Product Type: Secondary Antibody
- Supplier: InvivoCrown
- Catalog Number: SIM0478-1mg
- Specification: 1mg
- Host: Human
- Reactivity: Human
Production and Purification Process
This recombinant biosimilar antibody is produced using advanced manufacturing processes in animal component-free facilities, utilizing only in vitro protein-free cell culture technology. The product undergoes a multi-step purification process, including chromatography with Protein A or G, to ensure high purity and low endotoxin levels, suitable for various rigorous research applications.
Research Areas and Applications
Main Research Areas:
- Asthma pathogenesis research
- Exploration of Acute Respiratory Distress Syndrome (ARDS)
- Studies related to Acute Lung Injury (ALI)
Application Types:
- ELISA: Suitable for quantitative detection of LIGHT protein
- FACS: Can be used for flow cytometry analysis of LIGHT expression on cell surfaces
- Functional assay: Functional studies of LIGHT signaling pathway
- Research in vivo: In vivo disease model research
Technical Parameters
- Immunogenicity: For detailed information, please refer to the product manual
- Cross-reactivity: Specifically binds to human LIGHT protein
- Storage Conditions:
- Short-term storage (1-2 weeks): 4°C
- Medium-term storage: -20°C, up to 12 months
- Long-term storage: -80°C
- Note: Avoid repeated freeze-thaw cycles to maintain antibody activity
Ordering Information
Catalog Number: SIM0478-1mg
Specification: 1mg
Supplier: InvivoCrown
Note: This product is for research use only and not for diagnostic or therapeutic purposes. For detailed technical information, please refer to the product manual or contact our technical support team.
Note: The information above may be subject to change due to factors such as product optimization and upgrades. Please consult Yakeyin Company for specific information.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验
技术资料暂无技术资料 索取技术资料






